To date, ELISA measurement of Aβ42, t-tau, and p-tau (referred to as an Alzheimer’s signature) in CSF is the most accepted method to diagnose probable AD, with a reported high sensitivity and specificity for the diagnosis of AD, even at an early stage [17]. The gene discussed is MAPT; the disease is Alzheimer disease.